BrainHQ for Schizophrenia

Study Name
e-CAeSAR Trial: Evaluation of a Cognitively Adaptive e-treatment in Schizophrenia-diagnosed Adults: A Remediation-based Approach

Institution
UCSF, Palo Alto VAMC, University of Texas Health Sciences, University of Miami, UCLA, University of North Carolina, Atlanta VAMC, Philadelphia VAMC, Georgia Health Sciences Center, Duke University Medical School, University of Rochester Medical Center

Author(s)
Keefe R, Vinogradov S, Buckley P, Caroff S, Duncan E, Jarskog F, Lamberti S, Nuechterlein K, Strassnig M, Velligan D, Yasmin S

Indication
Schizophrenia

Description
The primary objective of this study in 132 people is to evaluate the effects of BrainHQ on the cognitive abilities, functional status and quality of life of individuals diagnosed with schizophrenia, as compared to a computer-based control. The study has been funded by the US National Institutes of Mental Health and is in progress.

Status
In-progress